The hospital pharmacy leader and the fight against drug diversion
A panel discussion on new tools and guidelines
Join Baker Tilly, Becker’s Hospital Review and other drug diversion specialists for an informative webinar on April 28, 2021 that will discuss drug diversion, pending guidelines for diversion detection and investigations, and best practices for following future guidelines. In addition, the group of panelists will discuss:
- The potential impact of the upcoming new guidelines for diversion
- How to build diversion processes
- Key members and roles of the team
- The benefits of automation, machine learning, and artificial intelligence to identify diversion
Speakers
- Janice Ahlstrom, FHIMSS, CPHIMS, CCSFP, RN, BSN, Director of Risk Advisory Services – Baker Tilly
- Julia Schimmelpfennig PharmD, MS, BCPS, CDE, Pharmacy Director of St. Elizabeth's Hospital at Hospital Sisters Health System
- Patrick Yoder, PharmD, Co-founder and Chief Executive Officer at LogicStream Health